Pietro Taverna

Pietro Taverna is an accomplished executive in translational medicine, currently serving as Vice President of Research & Translational Medicine at Karyopharm Therapeutics Inc. since February 2023. Prior to this role, Pietro held senior leadership positions, including Executive Director of Translational Sciences at Constellation Pharmaceuticals and Vice President of Translational Medicine & Nonclinical Development at Sunesis Pharmaceuticals. Pietro's extensive experience encompasses strategic oversight of clinical development for various oncology treatments, with notable contributions to Vecabrutinib and SNS-510. Former roles at Astex Pharmaceuticals and Chiron Corp. involved leading translational pharmacology efforts for novel cancer therapies. Educational qualifications include a PhD in Pharmacological Research and postdoctoral training from prestigious institutions.